EUVIMEDSkopri EUVIMED
Crossref

Is Non‐Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?

Friederike S Luetzenberg iD, James Wald, Ella A Chrenka, Manuela Fina iD

Otolaryngology–Head and Neck Surgery · 2026

DOI: 10.1002/ohn.70080 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2026. Written by Friederike S Luetzenberg and 3 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota, USA. Major MEDLINE topics: Cholesteatoma, Middle Ear. 31 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

The objective of this study was to investigate predictive factors for residual disease in acquired cholesteatoma and determine whether the quality of the matrix having a continuous versus disrupted lining—sac versus nonsac contained—impacts the outcomes. Study Design Retrospective cohort study.

Setting

Academic teaching hospital.

Methods

Pediatric and adult EAONO‐JOS‐staged acquired cholesteatoma operated with endoscopic and combined approaches by the senior author from January 2015 to November 2023 were included. Presence of residual disease was determined through second‐look surgery, MRI with DWI, or by clinical examination following canal wall down mastoidectomy. Initial occurrence of residual disease was examined relative to age, sac versus non‐sac contained matrix, ossicular status, and surgical approaches using Cox proportional hazard models. Kaplan‐Meier curves were used to visualize time to disease stratified by predictive factors.

Results

Out of 105 ears included, 42% had residual disease. In isolation, non‐sac contained cholesteatoma (hazard ratio [HR] 3.89, 95% confidence interval [CI] 1.53‐9.89), pediatric patients (HR 1.97, 95% CI 1.01‐3.85), incus erosion (HR 2.43, 95% CI 1.17‐5.05), and stapes erosion (HR 2.01, 95% CI 1.02‐4.00) were significantly more likely to develop residual disease. EAONO/JOS stage and surgical approach were not significantly related. In multivariable modeling, only matrix quality retained significance, with non‐sac contained matrix associated with a threefold higher hazard of residual disease (HR 3.05, 95% CI 1.17‐7.93).

Conclusion

When accounting for several factors inherent to the disease process as well as surgical approach, a non‐sac contained cholesteatoma matrix was 3 times more likely to lead to residual disease in acquired cholesteatoma among all ages.

Subjects

MeSH terms (MEDLINE)

Cholesteatoma, Middle EarHumansRetrospective StudiesMaleFemaleChildAdolescentAdultMiddle AgedChild, PreschoolMastoidectomyYoung AdultEndoscopy

Author keywords

cholesteatomaincus erosionmatrixresidual disease

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
  • University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • HealthPartners Institute, HealthPartners, Bloomington, Minnesota, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Regions Hospital, HealthPartners, St. Paul, Minnesota, USA.

ORCID profiles: Friederike S Luetzenberg, Manuela Fina

Cite

APA

Luetzenberg, F. S., Wald, J., Chrenka, E. A., & Fina, M. (2026). Is Non‐Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70080

Vancouver

Luetzenberg FS, Wald J, Chrenka EA, Fina M. Is Non‐Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70080

BibTeX
@article{Luetzenberg2026,
  author = {Luetzenberg, Friederike S and Wald, James and Chrenka, Ella A and Fina, Manuela},
  title = {Is Non‐Sac Contained Matrix a Major Predictor for Residual Disease in Acquired Cholesteatoma?},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2026},
  doi = {10.1002/ohn.70080}
}
Start for free →